BioNTech sets sights on oral mRNA vaccines with deal to access Matinas delivery technology
BioNTech has reached an agreement to investigate the oral delivery of mRNA vaccines. The German mRNA specialist will investigate the potential for a lipid nanocrystal (LNC) platform to enable new vaccine formulations in collaboration with Matinas BioPharma. BioNTech was thrust into the biotech big leagues by the pandemic, as the vaccine it found and produced with Pfizer became a cornerstone of COVID-19 vaccination.... Read more »
Posted on : Wednesday , 13th April 2022